Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening

The Roswell AIR (Awareness, Information and Resources for Lung Cancer Screening) Program: A Community-Partnered Lung Cancer Screening Intervention

This trial investigates an educational program called Awareness, Information, and Resources for Lung Cancer Screening Program in improving knowledge about lung cancer screening in medically underserved communities. This program aims to educate and remove barriers to lung cancer screening among medically underserved community members who are eligible for lung cancer screening, and to improve access to evidence-based screening guidelines for early detection for lung cancer in the Western New York area.

Study Overview

• Status: Completed
• Conditions: Lung Carcinoma
• Intervention / Treatment: Behavioral: Educational Intervention; Behavioral: Questionnaire Administration

Detailed Description

PRIMARY OBJECTIVES:

I. Collaborate with community organizations and leaders to leverage community-based assets to disseminate education about lung cancer screening.

II. Reach medically underserved, high risk community members. III. Enhance lung cancer screening knowledge among medically underserved, high risk community members.

IV. Navigate screening-eligible community members to lung cancer screening.

OUTLINE:

Participants complete the Roswell Awareness, Information and Resources for Lung Cancer Screening (AIR) Program over 45 minutes and then receive the High-Risk Lung Cancer Tip Sheet.

• Study Type: Interventional
• Enrollment (Actual): 292
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • New York
    • Buffalo, New York, United States, 14263
      • Roswell Park Cancer Institute

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Members of all races and ethnic groups are eligible for this study

Exclusion Criteria:

• Adults unable to consent

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Prevention (AIR Program); Participants complete the Roswell Awareness, Information and Resources for Lung Cancer Screening (AIR) Program over 45 minutes and then receive the High-Risk Lung Cancer Tip Sheet..	Behavioral: Educational Intervention; Complete AIR Program and receive the High-Risk Lung Cancer Tip Sheet; Other Names: Education for Intervention; Intervention by Education; Intervention through Education; Intervention, Educational; Behavioral: Questionnaire Administration; Ancillary studies

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of programs offered		Up to 1 year
Average number of attendees at each site		Up to 1 year
Demographics of attendees at each site		Up to 1 year
Number of medically underserved, high risk community members reached		Up to 1 year
Percent change in lung cancer screening awareness as assessed before and after program completion	Pre and post questionnaire to be given to participants	Up to 1 year
Percent change in knowledge of eligibility guidelines for screening as assessed before and after program completion	Pre and post questionnaire to be given to participants before and after educational sessions	Up to 1 year
Percent Change in knowledge of benefits of early detection as assessed before and after program completion	Pre and post questionnaire to be completed by participants before and after educational sessions	Up to 1 year
Change in fear, worry, and increased health-related self-efficacy	Pre and post questionnaire to be completed by participants before and after educational sessions	Up to 1 year
Number of screening eligible individuals reached		Up to 1 year
Number of screening eligible individuals navigated to lung cancer screening		Up to 1 year

Collaborators and Investigators

• Sponsor: Roswell Park Cancer Institute
• Investigators: Principal Investigator: Elizabeth Bouchard, Roswell Park Cancer Institute

Study record dates

Study Major Dates

• Study Start (Actual): November 30, 2020
• Primary Completion (Actual): August 25, 2021
• Study Completion (Actual): August 25, 2022

Study Registration Dates

• First Submitted: November 5, 2020
• First Submitted That Met QC Criteria: November 13, 2020
• First Posted (Actual): November 19, 2020

Study Record Updates

• Last Update Posted (Actual): September 28, 2022
• Last Update Submitted That Met QC Criteria: September 27, 2022
• Last Verified: September 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Neoplasms; Lung Diseases; Neoplasms by Site; Respiratory Tract Neoplasms; Thoracic Neoplasms; Lung Neoplasms
• Other Study ID Numbers: I 781020 (Other Identifier: Roswell Park Cancer Institute); NCI-2020-08297 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No